Erica Stringer-Reasor Selected Research

Erica Stringer-Reasor Research Topics

Disease

12	Neoplasms (Cancer) 01/2023 - 06/2017
11	Breast Neoplasms (Breast Cancer) 12/2023 - 06/2017
7	Triple Negative Breast Neoplasms 01/2023 - 08/2018
4	Pathologic Complete Response 12/2022 - 01/2020
2	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2017
2	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 08/2019
1	Microsatellite Instability 01/2022
1	Circulating Neoplastic Cells 01/2022
1	Hyperglycemia 10/2021
1	Nausea 01/2021
1	Alopecia (Baldness) 01/2021
1	Brain Neoplasms (Brain Tumor) 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Fatigue 01/2021
1	Headache (Headaches) 01/2021
1	Neutropenia 01/2021
1	Vomiting 01/2021
1	Carcinoma (Carcinomatosis) 08/2019

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 12/2023 - 06/2017
7	Hormones (Hormone)IBA 12/2023 - 08/2018
3	ErbB Receptors (EGF Receptor)IBA 01/2023 - 01/2020
3	pembrolizumabIBA 01/2022 - 08/2019
2	Trastuzumab (Herceptin)FDA Link 12/2023 - 01/2021
2	Paclitaxel (Taxol)FDA LinkGeneric 12/2023 - 10/2021
2	gedatolisibIBA 01/2023 - 01/2023
2	Fulvestrant (Faslodex)FDA Link 01/2023 - 01/2022
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2022 - 01/2020
2	PlatinumIBA 01/2021 - 08/2019
1	trebananibIBA 12/2023
1	Cisplatin (Platino)FDA LinkGeneric 01/2023
1	Cyclin-Dependent Kinase 4IBA 01/2023
1	exemestane (Aromasin)FDA Link 01/2023
1	dacomitinibIBA 01/2023
1	Docetaxel (Taxotere)FDA Link 01/2023
1	ribociclibIBA 01/2023
1	STA 9090IBA 12/2022
1	CateninsIBA 01/2022
1	dostarlimabIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	AlpelisibIBA 01/2022
1	Circulating Tumor DNAIBA 01/2022
1	Metformin (Glucophage)FDA LinkGeneric 10/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2021
1	ganitumabIBA 10/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2021
1	Hemoglobins (Hemoglobin)IBA 10/2021
1	Capecitabine (Xeloda)FDA Link 01/2021
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2021
1	cofetuzumab pelidotinIBA 01/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2021
1	tucatinibIBA 01/2021
1	MK 2206IBA 01/2020
1	TOR Serine-Threonine KinasesIBA 01/2020
1	niraparibIBA 08/2019
1	Bevacizumab (Avastin)FDA Link 08/2019
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 08/2019
1	Poly Adenosine Diphosphate RiboseIBA 08/2019
1	MicroRNAs (MicroRNA)IBA 06/2017
1	Tumor Biomarkers (Tumor Markers)IBA 06/2017

Therapy/Procedure

8	Therapeutics 01/2023 - 01/2020
6	Neoadjuvant Therapy 12/2022 - 08/2018
4	Drug Therapy (Chemotherapy) 12/2023 - 08/2019
1	Investigational Therapies (Experimental Therapy) 12/2023
1	Adjuvant Chemotherapy 01/2020